Qing Hai Zhao
Corporate Officer/Principal at ADAGENE INC.
Profile
Qing Hai Zhao is currently the Chief Manufacturing Officer at Adagene, Inc. Prior to this, he held positions as Executive Director & Head-Chemistry at NGM Biopharmaceuticals, Inc., Vice President-Manufacturing at AnaptysBio, Inc., and VP-Technical Development & Manufacturing at Forty Seven, Inc. Zhao received a doctorate degree from the University of Uppsala in 1998, an undergraduate degree from East China University of Science & Technology in 1982, and a graduate degree from Zhongshan Hospital Fudan University.
Qing Hai Zhao active positions
Companies | Position | Start |
---|---|---|
ADAGENE INC. | Corporate Officer/Principal | 2020-09-30 |
Former positions of Qing Hai Zhao
Companies | Position | End |
---|---|---|
FORTY SEVEN, INC. | Corporate Officer/Principal | 2020-09-30 |
ANAPTYSBIO, INC. | Corporate Officer/Principal | 2016-12-31 |
NGM BIOPHARMACEUTICALS, INC. | Director/Board Member | 2015-12-31 |
Training of Qing Hai Zhao
University of Uppsala | Doctorate Degree |
East China University of Science & Technology | Undergraduate Degree |
Zhongshan Hospital Fudan University | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 3 |
---|---|
ANAPTYSBIO, INC. | Health Technology |
NGM BIOPHARMACEUTICALS, INC. | Health Technology |
ADAGENE INC. | Health Technology |
Private companies | 1 |
---|---|
Forty Seven, Inc.
Forty Seven, Inc. Pharmaceuticals: MajorHealth Technology Forty Seven, Inc. develops therapies that target cancer immune evasion pathways. It develops Hu5F9-G4, a monoclonal antibody against human CD47 that potentially has applications spanning multiple tumor types and treatment modalities. The company was founded by Irving L. Weissman, Ravi Majeti, Mark Chao and Jens-Peter Volkmer in 2014 and is headquartered in Menlo Park, CA. | Health Technology |
- Stock Market
- Insiders
- Qing Hai Zhao